Literature DB >> 23910589

Comparison of risk prediction with the CKD-EPI and MDRD equations in acute decompensated heart failure.

Sergio Manzano-Fernández1, Pedro J Flores-Blanco, Juan I Pérez-Calvo, Francisco J Ruiz-Ruiz, Francisco J Carrasco-Sánchez, José L Morales-Rull, Luis Galisteo-Almeda, Domingo Pascual-Figal, Mariano Valdes, James L Januzzi.   

Abstract

BACKGROUND: Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equations estimate glomerular filtration rate (eGFR) more accurately than the Modification of Diet in Renal Disease (MDRD) equation. The aim of this study was to evaluate whether CKD-EPI equations based on serum creatinine and/or cystatin C (CysC) predict risk for adverse outcomes more accurately than the MDRD equation in a hospitalized cohort of patients with acute decompensated heart failure (ADHF). METHODS AND
RESULTS: A total of 526 subjects with ADHF were studied. Blood was collected within 48 hours from admission. eGFR was calculated with the use of MDRD and CKD-EPI equations. The occurrences of mortality and heart failure (HF) hospitalization were recorded. Over the study period (median 365 days [interquartile range 238-370]), 305 patients (58%) died or were rehospitalized for HF. Areas under the receiver operator characteristic curves for CKD-EPI CysC and CKD-EPI creatinine-CysC equations were significantly higher than that for the MDRD equation, especially in patients with >60 mL min(-1) 1.73 m(-2). After multivariate adjustment, all eGFR equations were independent predictors of adverse outcomes (P < .001). However, only CKD-EPI CysC and CKD-EPI creatinine-CysC equations were associated with significant improvement in reclassification analyses (net reclassification improvements 10.8% and 12.5%, respectively).
CONCLUSIONS: In patients with ADHF, CysC-based CKD-EPI equations were superior to the MDRD equation for predicting mortality and/or HF hospitalization especially in patients with >60 mL min(-1) 1.73 m(-2), and both CKD-EPI equations improved clinical risk stratification.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute heart failure; CKD-EPI; MDRD; prognosis

Mesh:

Year:  2013        PMID: 23910589     DOI: 10.1016/j.cardfail.2013.05.011

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  8 in total

1.  Cystatin C-based CKD-EPI equations and N-terminal pro-B-type natriuretic peptide for predicting outcomes in acutely decompensated heart failure.

Authors:  Pedro J Flores-Blanco; Sergio Manzano-Fernández; Juan I Pérez-Calvo; Francisco J Pastor-Pérez; Francisco J Ruiz-Ruiz; Francisco J Carrasco-Sánchez; José L Morales-Rull; Domingo Pascual-Figal; Luis Galisteo-Almeda; James L Januzzi
Journal:  Clin Cardiol       Date:  2015-02-06       Impact factor: 2.882

2.  Estimated Glomerular Filtration Rate and 6-Minute Walk Distance in African Americans with Mild to Moderate Heart Failure.

Authors:  Karen M Vuckovic; Houry Puzantian
Journal:  Cardiorenal Med       Date:  2017-05-24       Impact factor: 2.041

3.  Comparison of Risk Prediction With the CKD-EPI and MDRD Equations in Non-ST-Segment Elevation Acute Coronary Syndrome.

Authors:  Pedro J Flores-Blanco; Ángel López-Cuenca; James L Januzzi; Francisco Marín; Marianela Sánchez-Martínez; Miriam Quintana-Giner; Ana I Romero-Aniorte; Mariano Valdés; Sergio Manzano-Fernández
Journal:  Clin Cardiol       Date:  2016-06-01       Impact factor: 2.882

4.  Letter to the Editor regarding the article 'Left atrial volume index in patients with heart failure and severely impaired left ventricular systolic function: the role of established echocardiographic parameters, circulating cystatin C and galectin-3' by Zivlas et al. (2017).

Authors:  Juan Pérez-Calvo; Jorge Rubio-Gracia; Claudia Josa-Laorden
Journal:  Ther Adv Cardiovasc Dis       Date:  2018-02-08

Review 5.  Cardiac Biomarkers in Advanced Heart Failure: How Can They Impact Our Pre-transplant or Pre-LVAD Decision-making.

Authors:  Imo Ebong; Sula Mazimba; Khadijah Breathett
Journal:  Curr Heart Fail Rep       Date:  2019-12

6.  Cystatin C and Muscle Mass in Patients With Heart Failure.

Authors:  Juan B Ivey-Miranda; Lesley A Inker; Matthew Griffin; Veena Rao; Christopher Maulion; Jeffrey M Turner; F Perry Wilson; W H Wilson Tang; Andrew S Levey; Jeffrey M Testani
Journal:  J Card Fail       Date:  2020-08-01       Impact factor: 5.712

Review 7.  Establishing the presence or absence of chronic kidney disease: Uses and limitations of formulas estimating the glomerular filtration rate.

Authors:  Ahmed Alaini; Deepak Malhotra; Helbert Rondon-Berrios; Christos P Argyropoulos; Zeid J Khitan; Dominic S C Raj; Mark Rohrscheib; Joseph I Shapiro; Antonios H Tzamaloukas
Journal:  World J Methodol       Date:  2017-09-26

8.  Acute Kidney Function Declines in the Context of Decongestion in Acute Decompensated Heart Failure.

Authors:  Wendy McCallum; Hocine Tighiouart; Jeffrey M Testani; Matthew Griffin; Marvin A Konstam; James E Udelson; Mark J Sarnak
Journal:  JACC Heart Fail       Date:  2020-06-10       Impact factor: 12.544

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.